ICD-10-CM Billable Code

E10.353

Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula

Clinical Classification Guidelines

Medical Intelligence & Overview

Type 1 diabetes mellitus is a chronic condition where the body's immune system attacks insulin-producing cells in the pancreas. When blood sugar levels remain high over time, it can lead to complications, including eye problems. One serious eye complication associated with diabetes is proliferative diabetic retinopathy, which involves abnormal growth of blood vessels in the retina. Sometimes, this condition results in traction retinal detachment, where scar tissue pulls the retina away from the underlying tissue, potentially threatening vision. Specifically, ICD-10 code E10.353 refers to cases where proliferative diabetic retinopathy causes traction retinal detachment that does not involve the central part of the retina, known as the macula.

Causes & Symptoms

Clinical Causes: Chronic high blood sugar levels associated with poorly controlled type 1 diabetes Progressive damage to retinal blood vessels leading to abnormal vessel growth (neovascularization) Formation of scar tissue (fibrosis) that exerts traction on the retina Long-standing diabetes duration increases risk Presence of other diabetic complications like hypertension that may accelerate eye damage

Key Symptoms: Blurred or distorted vision Floaters or spots in the visual field Sudden or gradual loss of peripheral or central vision Dark areas or shadows in the visual field No symptoms in early stages; vision changes may develop gradually

Diagnostic & Treatment

Diagnosis Path: Diagnosing this condition involves comprehensive eye examinations, including dilated retinal exams where an ophthalmologist looks for abnormal blood vessels and scar tissue. Imaging techniques such as retinal photography or optical coherence tomography (OCT) can help assess the extent of retinal detachment and other structural changes. Fluorescein angiography may also be used to highlight abnormal blood vessel growth within the retina.

Treatment Protocols: Treatment strategies aim to prevent vision loss and may include: - **Laser Photocoagulation:** To seal leaking blood vessels and reduce abnormal vessel growth - **Intravitreal Injections:** Medications such as anti-VEGF agents can help decrease abnormal vessel growth and address edema - **Surgical Intervention:** Vitrectomy procedures are often performed to remove scar tissue and relieve traction on the retina, especially in cases of traction retinal detachment - **Blood Sugar Control:** Strict management of blood glucose levels to slow or prevent progression of diabetic retinopathy Early detection and management are vital in preserving vision, making regular eye exams crucial for individuals with type 1 diabetes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E10.353 a billable ICD-10 code?
Yes, E10.353 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E10.353?
Clinical documentation must specify the nature of Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

traction proliferative diabetic retinal retinopathy mellitus detachment macula diabetes